The Critical Role of Pelvic Rehabilitation After Gynecologic & Bladder Cancer Treatment

Cancer treatment, even when curative, often leaves a cascade of physiological consequences on the pelvic region. Pelvic rehabilitation clinicians are uniquely positioned to help survivors reclaim function, reduce symptoms, and improve quality of life.

Why Rehabilitation Matters in Oncology - Especially for Pelvic Practitioners
Before jumping into the how, it’s important to acknowledge the why. Pelvic morbidity following gynecologic cancers such as cervical, endometrial, vulvar, and ovarian malignancies is strikingly prevalent. Many survivors experience urinary symptoms, fecal dysfunction, dyspareunia, vaginal stenosis, and pelvic floor muscle hypertonicity. Studies have shown that lower urinary tract dysfunction can affect up to 70–85% of patients after cervical cancer surgery, and as many as two-thirds report sexual dysfunction (1). The causes of these complications are multifactorial and can stem from surgical disruption, radiation-induced fibrosis and vascular changes, chemotherapy side effects, nerve injury, hormonal alterations, and scar tissue formation. These effects are often cumulative and synergistic, making each patient’s recovery trajectory unique.

Moreover, the prognosis is non-linear; impairments may not appear until months or even years after treatment as fibrosis and tissue stiffening continue to evolve. Encouragingly, research demonstrates that when rehabilitation interventions are applied early and consistently, patients can achieve significant and lasting improvements - some maintained even a year post-treatment (2). Given these realities, pelvic rehabilitation is an essential component of comprehensive survivorship care.

Rehabilitation After Gynecologic & Bladder Cancer - What the Evidence Says
One of the most well-studied areas in oncologic pelvic rehabilitation focuses on gynecologic cancer survivors experiencing dyspareunia during intercourse. A mixed-methods study of 31 women who participated in a 12-week multimodal pelvic physical therapy program - combining education, manual therapy, and pelvic floor muscle exercises - demonstrated significant improvements from baseline to one year in pain, sexual function, urinary symptoms, psychological wellbeing, and body image (2).

Importantly, the benefits achieved at the end of treatment were maintained 12 months later, suggesting long-term durability of outcomes. Qualitative interviews from the same group further revealed that participants perceived meaningful reductions in pain, improved sexual comfort, and enhanced urinary control (2).

A growing body of systematic reviews and recent clinical trials supports the superiority of multimodal pelvic floor interventions that combine pelvic floor muscle training, education, and adjunct therapies over single-modality approaches. These integrated programs consistently demonstrate broader improvements in bladder, bowel, sexual, and general pelvic floor function compared to education or passive interventions alone (3). A 2024 umbrella review echoed these findings, highlighting that multimodal therapy can alleviate incontinence and sexual dysfunction while improving pelvic floor muscle performance, though higher-quality studies are still needed. Manual therapy techniques, including scar mobilization, myofascial release, and neural mobility, are also frequently incorporated. Particularly in areas affected by surgery or radiation, to counteract tissue stiffening, fibrosis, and adhesions that can limit recovery (4).

While the literature on bladder cancer rehabilitation remains more limited, emerging research indicates promising results. A 2024 review on rehabilitation following orthotopic neobladder (ONB) reconstruction identified urinary incontinence as a frequent complication and underscored pelvic floor muscle training as a key component of post-operative management (5). The same review emphasized the need to standardize pelvic floor rehabilitation protocols to reduce practitioner variability and improve outcomes across care settings.

More broadly, evidence from cancer survivor cohorts demonstrates that non-invasive pelvic floor rehabilitation (PFR), including manual therapy, neuromuscular re-education, and targeted education, can effectively reduce self-reported pain, improve voiding and defecation coordination, and address pelvic dysfunction across diverse cancer types (4). In addition, case reports have described comprehensive, individualized physical therapy programs after pelvic radiotherapy that successfully integrate internal and external techniques, dilator use, and adherence support to restore function and comfort (6).

Although the evidence base for bladder cancer–specific rehabilitation is still developing, the principles established in gynecologic oncology, such as progressive pelvic floor training, manual and soft-tissue interventions, and individualized patient education, are highly translatable. These approaches can be adapted to the unique anatomical and surgical circumstances of bladder cancer survivors, including those with urinary diversions or neobladders, ensuring a comprehensive and compassionate path toward recovery and quality-of-life restoration.

A Glimpse into Emerging Trends & Gaps
The field of oncologic pelvic rehabilitation is rapidly evolving, with new technologies and research directions poised to expand access, precision, and personalization of care. One promising development is the rise of e-rehabilitation programs for cancer survivors. A 2025 proof-of-concept study evaluated an online pelvic health e-rehabilitation platform that combined educational modules with virtual exercise coaching for gynecologic cancer survivors experiencing urogenital impairments. The study found the intervention to be both feasible and acceptable, suggesting that digital delivery could improve continuity of care and extend access to underserved or geographically remote populations (7).

Parallel to this, advances in digital prediction modeling are offering new possibilities for individualized rehabilitation planning. Recent multimodal deep learning models—such as MultiSurv—can integrate imaging, histopathology, and clinical data to predict recurrence and survival outcomes in bladder cancer. These predictive tools may one day assist clinicians in stratifying rehabilitation risk, identifying high-need patients earlier, and tailoring intervention intensity accordingly (8).

Similarly, breakthroughs in artificial intelligence–driven imaging are improving structural visualization of the pelvic floor. Semi-supervised deep learning models for MRI segmentation are becoming increasingly accurate, offering potential for enhanced mapping of pelvic anatomy, fibrosis, and treatment-related changes that could inform individualized rehabilitation strategies (8).

Despite these innovations, substantial gaps remain at the intersection of oncology and rehabilitation. There is still a lack of large-scale randomized controlled trials examining pelvic floor rehabilitation in bladder cancer survivors, limited long-term follow-up data, and no universally standardized rehabilitation protocols across cancer types. Moreover, the field would benefit from stronger evidence integrating internal manual therapy, neural modulation, and multimodal therapeutic approaches into oncology-specific rehabilitation frameworks. Bridging these gaps will be critical to optimizing recovery trajectories and ensuring that all cancer survivors have access to evidence-based pelvic health care.

Learn More in Our Upcoming Course
If you are a pelvic rehabilitation clinician seeking to deepen your expertise in managing cancer-associated pelvic dysfunction join us in the upcoming Oncology of the Pelvic Floor Level 2B course scheduled for November 1–2, 2025. This intermediate level course covers gynecologic and bladder cancers and includes risk factors, diagnostic pathways, and prognostic considerations. Participants will explore the sequelae of medical cancer treatments and gain insight into how surgery, chemotherapy, and radiation impact pelvic structures, tissue health, neural integrity, and overall quality of life.

Oncology of the Pelvic Floor Level 2B presents evidence-based rehabilitation strategies, nutritional considerations, and practical home program options that patients can implement between sessions. Clinicians will receive evaluation and treatment interventions that can be immediately integrated into practice, bridging the gap between research and real-world application.

Reference:

1. Li, X., Liu, L., He, J., Yan, J., & Wang, Y. (2023). Analysis of the effectiveness of the application of pelvic floor rehabilitation exercise and the factors influencing its self-efficacy in postoperative patients with cervical cancer. Frontiers in Oncology, 13, 1118794. https://doi.org/10.3389/fonc.2023.1118794
2. Cyr, P., Dostie, R., Camden, C., Dumoulin, C., Bessette, P., Pina, A., Gotlieb, W. H., Lapointe-Milot, K., Mayrand, H., & Morin, M. (2022). Improvements following multimodal pelvic floor physical therapy in gynecological cancer survivors suffering from pain during sexual intercourse: Results from a one-year follow-up mixed-method study. PLOS ONE, 17(1), e0262844. https://doi.org/10.1371/journal.pone.0262844
3. Cyr, MP., Jones, T., Brennen, R. et al.Effectiveness of Pelvic Floor Muscle and Education-Based Therapies on Bladder, Bowel, Vaginal, Sexual, Psychological Function, Quality of Life, and Pelvic Floor Muscle Function in Females Treated for Gynecological Cancer: A Systematic Review. Curr Oncol Rep 26, 1293–1320 (2024). https://doi.org/10.1007/s11912-024-01586-7
4. Kone AM, Roldan SP, Velez V, Roldan CJ. Non-Invasive Pelvic Floor Rehabilitation in Cancer Population. J Exp Pathol. 2024; 5(1): 14-20. https://www.scientificarchives.com/article/non-invasive-pelvic-floor-rehabilitation-in-cancer-population
5. Xu M, Chen S, Liu X, Luo Y, Wang D, Lu H, Jiang M, Chen X. Best evidence for rehabilitation management of urinary incontinence in patients with bladder cancer following orthotopic neobladder reconstruction. Asia Pac J Oncol Nurs. 2024 Dec 26; 12: 100647. doi: 10.1016/j.apjon.2024.100647. PMID: 39896758; PMCID: PMC11782885. https://pmc.ncbi.nlm.nih.gov/articles/PMC11782885/
6. Coughenour, E., Alkhameys, F., & Sharma, N. K. (2024). Rehabilitation of pelvic floor dysfunction after radiation therapy for a rare gynecological cancer: A case report. Gynecologic Oncology Reports, 56, 101534. https://doi.org/10.1016/j.gore.2024.101534
7. Bernard S, Perreault K, Pepin D, Gauthier LR, Roy-Richard C, Lamontagne MÈ, Dalzell MA, Mcneely ML. A pelvic health eRehabilitation program to address urogenital impairments after breast and gynecologic cancer: A proof-of-concept study protocol. Digit Health. 2025 Sep 24; 11: 20552076251382088. doi: 10.1177/20552076251382088. PMID: 41018515; PMCID: PMC12461042. https://pubmed.ncbi.nlm.nih.gov/41018515/
8. Wahab, N., Alzaid, E., Lv, J., Shephard, A., & Raza, S. E. (2025). ModalSurv: A Multimodal Deep Survival Framework for Prostate and Bladder Cancer. ArXiv. https://arxiv.org/abs/2509.05037